Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Atopic Dermatitis
Interventions
DEVICE

LimpiAD cream 2,5% plus

A topical formulation that contains Hyaluronic Acid conjugated with a bacterial wall fragment of Cutibacterium species (HAc-40) and an emollient base. LimpiAD exerts its post-biotic action through the seizure/ trapping and inactivation of catabolites and / or toxins produced by S. aureus as well as protecting the hydrolipidic film, especially in case of dryness, itching, and, in conditions of altered microbiome

OTHER

Vehicle

"Vehicle of LimpiAD cream 2.5 % plus which has the qualities of an emollient technically enriched with active ingredients known for their use in AD (plus emollient) - having the same ingredients of LimpiAD 2.5% Plus cream but without the HAc-40 component."

OTHER

Emollient

Standard emollient used as neutral control, having only a moisturizing and skin barrier action, which represents the basic standard treatment (basic therapy) of atopic dermatitis according to the European Guidelines.

Trial Locations (5)

Unknown

RECRUITING

University of Bari Hospital, Bari

RECRUITING

University of Modena e Reggio Emilia, Modena

RECRUITING

University of Naples Hospital, Naples

TERMINATED

S. Gallicano Hospital, Rome

RECRUITING

University Rome La Sapienza (Hospital Umberto I), Rome

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aileens Pharma SRL

INDUSTRY

NCT05971355 - Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis | Biotech Hunter | Biotech Hunter